June 09, 2016

Brian Elliott, CEO of Procela is invited to address the 2016 High Level Meeting on Ending AIDS at the UN HQ in New York. In his address, Brian warns of a looming crisis in access to HIV/AIDS medication, due to over-reliance on too few ARV suppliers. 

March 16, 2017

Brian Elliott, CEO of Procela Consulting tells the Financial Times about the looming crisis in access to HIV medication, with just four companies supplying the bulk of antiretroviral medication to poorer countries. 

April 17, 2017

Brian Elliott's highlighting of the risks inherent in relying on a small number of manufacturers prompts review of current supply arrangements and response from the Global Fund.